{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:57:08Z","timestamp":1785254228653,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.bone.2022.116455","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T21:29:05Z","timestamp":1654637345000},"page":"116455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Characteristics of bisphosphonate and non-bisphosphonate related atypical femoral fracture in a South East Asian population \u2013 Secondary analysis"],"prefix":"10.1016","volume":"162","author":[{"given":"L.U.","family":"Gani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.F.","family":"Anthony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.M.","family":"Dacay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.T.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.R.","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.F.J.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2022.116455_bb0005","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF01623184","article-title":"Hip fractures in the elderly: a world-wide projection","volume":"2","author":"Cooper","year":"1992","journal-title":"Osteoporos.Int."},{"key":"10.1016\/j.bone.2022.116455_bb0010","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1210\/jc.2012-1027","article-title":"Benefits and risks of bisphosphonate therapy for osteoporosis","volume":"97","author":"Khosla","year":"2012","journal-title":"J.Clin.Endocrinol.Metab."},{"key":"10.1016\/j.bone.2022.116455_bb0015","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group","volume":"348","author":"Black","year":"1996","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.bone.2022.116455_bb0020","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal OsteoporosisA randomized controlled trial","volume":"282","author":"Harris","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2022.116455_bb0025","doi-asserted-by":"crossref","first-page":"711","DOI":"10.7326\/M14-0317","article-title":"Comparative effectiveness of pharmacologic treatments to prevent fractures: an updated systematic review","volume":"161","author":"Crandall","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bone.2022.116455_bb0030","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1210\/jc.2019-00192","article-title":"Efficacy of pharmacological therapies for the prevention of fractures in postmenopausal women: a network meta-analysis","volume":"104","author":"Barrionuevo","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2022.116455_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10515","article-title":"Incidence of atypical femoral fracture and its mortality in a single center in Singapore","volume":"5","author":"Gani","year":"2021","journal-title":"JBMR Plus"},{"key":"10.1016\/j.bone.2022.116455_bb0040","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1007\/s00198-017-4112-2","article-title":"Atypical subtrochanteric fractures in Korean hip fracture study","volume":"28","author":"Lee","year":"2017","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2022.116455_bb0045","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00776-014-0572-9","article-title":"Stress fracture of the bowed femoral shaft is another cause of atypical femoral fracture in elderly Japanese: a case series","volume":"19","author":"Oh","year":"2014","journal-title":"J. Orthop. Sci."},{"key":"10.1016\/j.bone.2022.116455_bb0050","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1007\/s00198-010-1384-1","article-title":"Atypical femoral stress fractures in bisphosphonate-free patients","volume":"22","author":"Tan","year":"2011","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2022.116455_bb0055","doi-asserted-by":"crossref","first-page":"4753170","DOI":"10.1155\/2016\/4753170","article-title":"Atypical complete femoral fractures associated with bisphosphonate use or not associated with bisphosphonate use: is there a difference?","volume":"2016","author":"Kim","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bone.2022.116455_bb0060","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1002\/jbmr.1719","article-title":"Incidence of atypical nontraumatic diaphyseal fractures of the femur","volume":"27","author":"Dell","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2022.116455_bb0065","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1056\/NEJMoa1010650","article-title":"Bisphosphonate use and atypical fractures of the femoral shaft","volume":"364","author":"Schilcher","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2022.116455_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: second report of a Task Force of the American Society for Bone and Mineral Research","volume":"29","author":"Shane","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2022.116455_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115319","article-title":"Asian ethnicity is associated with atypical femur fractures in an Australian population study","volume":"135","author":"Nguyen","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.bone.2022.116455_bb0080","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1056\/NEJMoa1916525","article-title":"Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates","volume":"383","author":"Black","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2022.116455_bb0085","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/jc.2005-0057","article-title":"Long-term safety of bisphosphonates","volume":"90","author":"Ott","year":"2005","journal-title":"J.Clin.Endocrinol.Metab."},{"key":"10.1016\/j.bone.2022.116455_bb0090","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3109\/17453674.2015.1004149","article-title":"Risk of atypical femoral fracture during and after bisphosphonate use","volume":"86","author":"Schilcher","year":"2015","journal-title":"Acta Orthop."},{"key":"10.1016\/j.bone.2022.116455_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115453","article-title":"Biological activity is not suppressed in mid-shaft stress fracture of the bowed femoral shaft unlike in \"typical\" atypical subtrochanteric femoral fracture: a proposed theory of atypical femoral fracture subtypes","volume":"137","author":"Oh","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.bone.2022.116455_bb0100","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1210\/er.2018-00001","article-title":"Atypical femur fractures: review of epidemiology, relationship to bisphosphonates, prevention, and clinical management","volume":"40","author":"Black","year":"2019","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bone.2022.116455_bb0105","first-page":"2304","article-title":"Evaluating atypical features of femur fractures: how change in radiological criteria influenced incidence and demography of atypical femur fractures in a community setting","volume":"32","author":"LeBlanc","year":"2017","journal-title":"J.BoneMiner.res."},{"key":"10.1016\/j.bone.2022.116455_bb0110","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bone.2015.10.016","article-title":"Assessment of femur geometrical parameters using EOS\u2122 imaging technology in patients with atypical femur fractures; preliminary results","volume":"83","author":"Morin","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.bone.2022.116455_bb0115","first-page":"87","article-title":"Fracture risk following an atypical femoral fracture","volume":"37","author":"B\u00e9gin","year":"2022","journal-title":"J.BoneMiner.Res."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328222001326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328222001326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:01:00Z","timestamp":1757613660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328222001326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":23,"alternative-id":["S8756328222001326"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2022.116455","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of bisphosphonate and non-bisphosphonate related atypical femoral fracture in a South East Asian population \u2013 Secondary analysis","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2022.116455","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116455"}}